Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC12962 structure
    GC12962Isatin
    CAS: 91-56-5
    纯度: >98.00%

    Isatin (Indoline-2,3-dione) 是一种有效的单胺氧化酶 (MAO) 抑制剂,IC50 为 3 μM。

  • GC12975 structure
    GC12975Indirubin
    CAS: 479-41-4
    纯度: >98.00%

    Indirubin是强效的周期蛋白依赖性激酶(CDKs)(IC 50 :50-100nmol/L)和糖原合成酶激酶-3β(GSK-3β)(IC 50 :5-50nmol/L)抑制剂,具有口服给药特性。

  • GC12989 structure
    GC12989PD184352 (CI-1040)
    CAS: 212631-79-3
    纯度: >99.50%

    A potent MEK inhibitor

  • GC13019 structure
    GC13019RG7112
    CAS: 939981-39-2
    纯度: >99.50%

    An inhibitor of the MDM2-p53 interaction

  • GC13028 structure
    GC13028SB 415286
    CAS: 264218-23-7
    纯度: >99.50%

    A selective inhibitor of GSK-3

  • GC13029 structure
    GC13029AZD2014
    CAS: 1009298-59-2
    纯度: >98.50%

    A potent dual mTORC1/2 inhibitor

  • GC13034 structure
    GC13034ML-291
    CAS: 1523437-16-2

    An activator of apoptosis through UPR

  • GC13035 structure
    GC13035Bay 11-7821
    CAS: 19542-67-7
    纯度: >99.50% / >95.00%

    Bay 11-7821是一种IκBα磷酸化和NF-κB抑制剂,选择性且不可逆地抑制TNF-α诱导的IκB-α磷酸化(IC 50 值约为10μM),并减少NF-κB和粘附分子的表达。Bay 11-7821抑制泛素特异性蛋白酶USP7和USP21,IC 50 分别为0.19、0.96μM。

  • GC13044 structure
    GC1304417-DMAG (Alvespimycin) HCl
    CAS: 467214-21-7
    纯度: >98.00%

    17-DMAG (Alvespimycin) HCl是一种有效的Hsp90的抑制剂,其IC 50 值为62nM。

  • GC13055 structure
    GC13055Mocetinostat (MGCD0103, MG0103)
    CAS: 726169-73-9
    纯度: >99.00%

    An orally available HDAC inhibitor

  • GC13058 structure
    GC13058NK 252
    CAS: 1414963-82-8
    纯度: >98.00%

    A Nrf2 activator

  • GC13065 structure
    GC13065Chelerythrine Chloride
    CAS: 3895-92-9
    纯度: >98.50% / >98.00%

    Chelerythrine Chloride是一种强效且可渗透细胞的蛋白激酶C(protein kinase C, PKC)抑制剂,IC 50 值为660nM。

  • GC13070 structure
    GC13070Cytarabine
    CAS: 147-94-4
    纯度: >99.50%

    Cytarabine(Ara-C)是一种胞嘧啶类似物,主要抑制DNA聚合酶的功能来阻断DNA合成。

  • GC13091 structure
    GC13091CP-724714
    CAS: 383432-38-0
    纯度: >99.00%

    A selective HER2/ErbB2 tyrosine kinase inhibitor

  • GC13163 structure
    GC13163Embelin
    CAS: 550-24-3
    纯度: >98.50%

    Embelin是一种非肽类、可穿透细胞的小分子X连锁凋亡抑制蛋白(XIAP)抑制剂,其IC₅₀值为4.1μM。

  • GC13168 structure
    GC13168AG 825
    CAS: 149092-50-2
    纯度: >98.00%

    An inhibitor of Her2/Neu tyrosine kinase activity

  • GC13194 structure
    GC13194RPI-1
    CAS: 269730-03-2
    纯度: >98.50%

    A RET kinase inhibitor

  • GC13202 structure
    GC13202D4476
    CAS: 301836-43-1
    纯度: >98.00%

    Inhibitor of CK1 and ALK5

  • GC13210 structure
    GC13210Flubendazole
    CAS: 31430-15-6
    纯度: >99.50%

    An anthelmintic

  • GC13215 structure
    GC13215Ascomycin(FK 520)
    CAS: 104987-12-4
    纯度: >99.50%

    A potent macrolide immunosuppressant

  • GC13219 structure
    GC13219ONO-4059
    CAS: 1351635-67-0
    纯度: >99.50%

    A derivative of ONO-4059

  • GC13232 structure
    GC13232Verbascoside
    CAS: 61276-17-3
    纯度: >99.50%

    Verbascoside是一种从Lantana camara中分离得到的蛋白激酶C(PKC)抑制剂,IC 50 值为25µM。

  • GC13246 structure
    GC13246Ibandronate sodium
    CAS: 138926-19-9
    纯度: >98.00%

    A bisphosphonate bone resorption inhibitor

  • GC13286 structure
    GC13286ZM336372
    CAS: 208260-29-1

    An activator of the Raf-1 signalling pathway